US502504A
(en)
*
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2288422A
(en)
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
DE920245C
(de)
|
1950-04-29 |
1954-11-18 |
Variapat Ag |
Verfahren zur Herstellung von aromatischen, farblosen, wasserloeslichen Trifluormethyl- und Sulfosaeuregruppen enthaltenden unsymmetrischen Harnstoffen bzw. Thioharnstoffen
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
NL90162C
(zh)
|
1953-03-06 |
|
|
|
US2745874A
(en)
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
NL193403A
(zh)
|
1953-12-22 |
1924-02-17 |
|
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(zh)
|
1959-08-14 |
|
|
|
NL277511A
(zh)
|
1961-04-21 |
|
|
|
CH428747A
(de)
|
1961-09-11 |
1967-01-31 |
Wander Ag Dr A |
Verfahren zur Herstellung neuer Harnstoff- und Thioharnstoffderivate
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
*
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(zh)
|
1965-06-09 |
1968-02-21 |
|
|
US3424762A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3424760A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424761A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
SE370866B
(zh)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3646059A
(en)
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3668222A
(en)
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
JPS5031039A
(zh)
|
1973-07-27 |
1975-03-27 |
|
|
US4116671A
(en)
|
1973-07-27 |
1978-09-26 |
Shionogi & Co., Ltd. |
3-Isoxazolylcarbamate derivatives
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
CH575208A5
(zh)
|
1973-07-30 |
1976-05-14 |
Ciba Geigy Ag |
|
US4001256A
(en)
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
*
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4071524A
(en)
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
*
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
*
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
WO1981002156A1
(en)
|
1980-01-25 |
1981-08-06 |
Reanal Finomvegyszergyar |
Process for the preparation of n-aryl-n'-(mono-or disubstiuted)-urea derivatives
|
EP0057797B1
(en)
|
1981-02-03 |
1986-06-25 |
Imperial Chemical Industries Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
DE3211851A1
(de)
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
IL69621A0
(en)
|
1982-09-02 |
1983-12-30 |
Duphar Int Res |
Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
|
CA1254212A
(en)
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
JPS6120039A
(ja)
|
1984-07-06 |
1986-01-28 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
DE3785507T2
(de)
|
1986-07-31 |
1993-07-29 |
Beecham Group Plc |
Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
|
NZ221964A
(en)
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
EP0264904A3
(en)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Pharmaceutical compositions containing benzoyl urea derivatives
|
DE3636190A1
(de)
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
DD253997A1
(de)
|
1986-11-26 |
1988-02-10 |
Karl Marx Uni Buero Fuer Neuer |
Verfahren zur herstellung von substituierten 2-arylureidophenolen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
ATE121742T1
(de)
|
1987-10-16 |
1995-05-15 |
Ciba Geigy Ag |
Schädlingsbekämpfungsmittel.
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
JPH0223337A
(ja)
|
1988-07-12 |
1990-01-25 |
Konica Corp |
新規なカプラーを含有するハロゲン化銀写真感光材料
|
JP2791156B2
(ja)
|
1988-08-23 |
1998-08-27 |
ザ ヌトラスウィート カンパニー |
強力甘味料としての置換アリール尿素
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
JP3002204B2
(ja)
*
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
*
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
US5177110A
(en)
|
1989-10-27 |
1993-01-05 |
Ciba-Geigy Corporation |
Injectable parasiticidal composition
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
WO1991019697A1
(en)
|
1990-06-19 |
1991-12-26 |
Meiji Seika Kabushiki Kaisha |
Pyridine derivative with angiotensin ii antagonism
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
AU646722B2
(en)
|
1991-01-21 |
1994-03-03 |
Shionogi Seiyaku Kabushiki Kaisha |
3-benzylidene-1-carbamoyl-2-pyrrolidone analog
|
JP2671693B2
(ja)
|
1991-03-04 |
1997-10-29 |
松下電器産業株式会社 |
バイオセンサおよびその製造法
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5185438A
(en)
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5100883A
(en)
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
NO921449L
(no)
|
1991-04-17 |
1992-10-19 |
American Home Prod |
Karbamater av rapamycin
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5185358A
(en)
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
WO1993004170A1
(en)
|
1991-08-23 |
1993-03-04 |
The United States Of America Represented By The Secretary, Department Of Health And Human Services |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
FR2683818B1
(fr)
|
1991-11-14 |
1993-12-31 |
Adir Cie |
Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
JPH07504429A
(ja)
|
1992-03-12 |
1995-05-18 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
5HT↓1cアンタゴニストとしてのインドール誘導体
|
EP0642498A1
(en)
|
1992-05-28 |
1995-03-15 |
Pfizer Inc. |
NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
|
ZA935111B
(en)
|
1992-07-17 |
1994-02-04 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
US5312820A
(en)
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
ZA935112B
(en)
|
1992-07-17 |
1994-02-08 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
KR950702994A
(ko)
|
1992-08-12 |
1995-08-23 |
로렌스 티. 웰츠 |
탁솔과 복합된, 단백질 키나제 억제제 및 관련 화합물(protein kinase inhibitors and related compounds combined with taxol)
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
DE4227989A1
(de)
|
1992-08-21 |
1994-06-09 |
Schering Ag |
Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(zh)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
WO1994023755A1
(en)
|
1993-04-09 |
1994-10-27 |
Board Of Regents Of The University Of Nebraska |
Novel methods and compositions for the treatment of ras-activated cancer with heterotypic anti-raf antisense oligonucleotides
|
GB9308802D0
(en)
|
1993-04-28 |
1993-06-09 |
Smithkline Beecham Plc |
Treatment
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US5378725A
(en)
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
US6514745B1
(en)
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
NZ264063A
(en)
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US6361773B1
(en)
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
NZ274063A
(en)
|
1993-09-17 |
1997-11-24 |
Smithkline Beecham Corp |
Cytokine suppressive anti-inflammatory drug binding protein (csbp) and its use
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(en)
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
DE69433501T2
(de)
|
1993-11-08 |
2004-11-04 |
Smithkline Beecham Corp. |
Oxazole zur behandlung von zytokinvermittelten erkrankungen
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
EP0729471A1
(en)
|
1993-11-19 |
1996-09-04 |
Abbott Laboratories |
Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
|
CN1046944C
(zh)
|
1993-12-17 |
1999-12-01 |
山道士有限公司 |
雷怕霉素类衍生物
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
*
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5447957A
(en)
*
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
WO1995033458A1
(en)
*
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
US5480906A
(en)
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
JPH10510512A
(ja)
|
1994-10-04 |
1998-10-13 |
藤沢薬品工業株式会社 |
尿素誘導体とacat阻害剤としての用途
|
EP0708085B1
(en)
|
1994-10-19 |
2002-07-17 |
Novartis AG |
Antiviral ethers of aspartate protease substrate isosteres
|
CA2161376C
(en)
*
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
JP3591938B2
(ja)
|
1994-10-27 |
2004-11-24 |
キヤノン株式会社 |
インクジェット用記録媒体及びこれを用いた画像形成方法
|
ES2158954T3
(es)
|
1994-10-28 |
2001-09-16 |
Novozymes As |
Proceso para el apresto quimico de polimeros insolubles.
|
TW313568B
(zh)
*
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
US5780483A
(en)
*
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
EP0809492A4
(en)
*
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
DE19512639A1
(de)
*
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
US5773459A
(en)
*
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
AU712193B2
(en)
|
1995-06-09 |
1999-10-28 |
Novartis Ag |
Rapamycin derivatives
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
MX9604165A
(es)
*
|
1995-09-18 |
1997-10-31 |
Sankyo Co |
Nuevos derivados de urea que tienen actividad inhibidora de acil-coa: colesterol acil transferasa; su preparacion y su uso terapeutico y profilactico.
|
US6075040A
(en)
|
1996-09-05 |
2000-06-13 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
WO1997017329A1
(fr)
|
1995-11-07 |
1997-05-15 |
Kirin Beer Kabushiki Kaisha |
Derives de quinoline et derives de quinazoline inhibant l'autophosphorylation d'un recepteur de facteur de croissance originaire de plaquettes, et compositions pharmaceutiques les contenant
|
EP0881217A4
(en)
*
|
1995-12-28 |
2000-01-26 |
Kureha Chemical Ind Co Ltd |
METHOD FOR PRODUCING PYRIDINE CARBOXAMIDES AND THIOCARBOXAMIDES
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
*
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6262113B1
(en)
*
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
US5891895A
(en)
*
|
1996-04-15 |
1999-04-06 |
Takeda Chemical Industries, Ltd. |
Hydroxypyridine derivatives their production and use
|
HUP0004421A3
(en)
|
1996-04-23 |
2002-10-28 |
Vertex Pharmaceuticals Inc Cam |
Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
*
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
IL126922A0
(en)
|
1996-05-24 |
1999-09-22 |
Neurosearch As |
Phenyl derivatives containing an acidic group their preparation and their use as chloride channel blockers
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
WO1997049399A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
WO1997049400A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
HUP9903922A3
(en)
*
|
1996-06-27 |
2001-12-28 |
Smithkline Beecham Corp |
Il-8 receptor antagonists
|
KR20000022274A
(ko)
*
|
1996-06-27 |
2000-04-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
Il-8 수용체 길항제
|
TR199800371T1
(xx)
|
1996-06-29 |
1998-06-22 |
Samjin Pharmaceutical Co.Ltd. |
Piperazine t�revleri ve bunlar�n haz�rlanma prosesi.
|
US6150415A
(en)
*
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
WO1998017207A1
(en)
|
1996-10-21 |
1998-04-30 |
Synthes Ag Chur |
Surgical prosthetic device
|
WO1998017267A1
(en)
|
1996-10-23 |
1998-04-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5965573A
(en)
*
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
CA2271693C
(en)
|
1996-11-15 |
2009-01-20 |
The Picower Institute For Medical Research |
Guanylhydrazones useful for treating diseases associated with t cell activation
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
WO1998022432A1
(fr)
|
1996-11-18 |
1998-05-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derives d'acylanilide a substitution acylamino ou composition comprenant ces derives
|
FR2755967B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
EP0991406A4
(en)
|
1997-01-23 |
2000-12-13 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US5929250A
(en)
*
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
DE69824837T2
(de)
|
1997-02-12 |
2005-08-25 |
Smithkline Beecham Corp. |
Il-8-rezeptor-antagonisten
|
US20020111495A1
(en)
|
1997-04-04 |
2002-08-15 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
AU738037B2
(en)
*
|
1997-04-04 |
2001-09-06 |
Pfizer Products Inc. |
Nicotinamide derivatives
|
ES2191292T3
(es)
*
|
1997-04-10 |
2003-09-01 |
Upjohn Co |
Compuestos antivirales poliaromaticos.
|
WO1998049150A1
(en)
|
1997-04-25 |
1998-11-05 |
Takeda Chemical Industries, Ltd. |
Triazine derivatives, their production and agrochemical composition
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
US6087381A
(en)
|
1997-05-22 |
2000-07-11 |
G. D. Searle & Company |
Pyrazole derivatives as p38 kinase inhibitors
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
EP0983260A2
(en)
|
1997-05-22 |
2000-03-08 |
G.D. Searle & Co. |
3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
|
AU7585598A
(en)
*
|
1997-05-23 |
1998-12-11 |
Bayer Corporation |
Raf kinase inhibitors
|
EP1019040B1
(en)
*
|
1997-05-23 |
2004-09-29 |
Bayer Corporation |
Aryl ureas for the treatment of inflammatory or immunomodulatory diseases
|
US6344476B1
(en)
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
US6187799B1
(en)
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US5985592A
(en)
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
JP2002504909A
(ja)
|
1997-06-13 |
2002-02-12 |
スミスクライン・ビーチャム・コーポレイション |
新規な置換ピラゾールおよびピラゾリン化合物
|
US6093742A
(en)
*
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
EP1020444A4
(en)
|
1997-06-27 |
2001-04-11 |
Kureha Chemical Ind Co Ltd |
6-PHENOXYPICOLINIC ACID, ALKYLIDENEHYDRAZIDE DERIVATIVES, THEIR PRODUCTION PROCESS, AND HERBICIDE
|
US6525065B1
(en)
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
AU9802198A
(en)
|
1997-10-21 |
1999-05-10 |
Pharmacia & Upjohn Company |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
IL135836A0
(en)
|
1997-10-31 |
2001-05-20 |
Aventis Pharma Ltd |
Substituted anilides
|
JP2001521934A
(ja)
|
1997-11-03 |
2001-11-13 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症薬としての芳香族ヘテロ環式化合物
|
US6022884A
(en)
*
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
HUP0102101A3
(en)
|
1997-11-10 |
2002-11-28 |
Bristol Myers Squibb Co |
Protein tyrosine kinase inhibitor benzothiazole derivatives and pharmaceutical compositions containing them
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
AU1407899A
(en)
|
1997-12-01 |
1999-06-16 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
US6174901B1
(en)
*
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
DE69834842T2
(de)
|
1997-12-22 |
2007-05-10 |
Bayer Pharmaceuticals Corp., West Haven |
Hemmung von raf-kinase unter verwendung von aryl- und heteroarylsubstituierten heterocyclischen harnstoffen
|
ATE297383T1
(de)
*
|
1997-12-22 |
2005-06-15 |
Bayer Pharmaceuticals Corp |
Hemmung der p38 kinase unter verwendung von symmetrischen und asymmetrischen diphenylharnstoffen
|
DE69829412T2
(de)
*
|
1997-12-22 |
2005-07-28 |
Bayer Pharmaceuticals Corp., West Haven |
Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
ES2155817T3
(es)
|
1997-12-22 |
2007-06-16 |
Bayer Pharmaceuticals Corp. |
Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas con arilo y heteroarilo.
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
NZ505844A
(en)
|
1997-12-22 |
2003-10-31 |
Bayer Ag |
Inhibition of raf kinase using substituted heterocyclic ureas
|
MXPA00006233A
(es)
*
|
1997-12-22 |
2002-09-18 |
Bayer Ag |
Inhibicion de la actividad de la cinasa p38 utilizando ureas heterociclicas sustituidas.
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
WO1999032109A1
(en)
|
1997-12-23 |
1999-07-01 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
AU1689999A
(en)
|
1997-12-25 |
1999-07-19 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal composition for percutaneous administration
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
JP2001501979A
(ja)
*
|
1998-01-21 |
2001-02-13 |
ザイモジェネティクス,インコーポレイティド |
カルシトニン擬態物としてのジアルキルウレア
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
AU741712B2
(en)
|
1998-02-18 |
2001-12-06 |
Theryte Limited |
Treating cancer
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
CA2337755C
(en)
|
1998-09-18 |
2008-07-29 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
AU1908000A
(en)
|
1998-11-06 |
2000-05-29 |
Basf Aktiengesellschaft |
Inhibition of the formation of vascular hyperpermeability
|
JP2002530436A
(ja)
|
1998-11-25 |
2002-09-17 |
ジェネティカ インコーポレイテッド |
増殖能を増強しかつ複製老化を防止する方法及び試薬
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
WO2000035454A1
(en)
|
1998-12-18 |
2000-06-22 |
Du Pont Pharmaceuticals Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
DE69926542T2
(de)
|
1998-12-25 |
2006-04-27 |
Teikoku Hormone Mfg. Co., Ltd. |
Aminopyrazolderivate
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
EP2298311B1
(en)
|
1999-01-13 |
2012-05-09 |
Bayer HealthCare LLC |
w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7351834B1
(en)
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
TWI284642B
(en)
*
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
ATE253051T1
(de)
|
1999-01-22 |
2003-11-15 |
Kirin Brewery |
Chinolinderivate und chinazolinderivate
|
AU2804400A
(en)
|
1999-02-12 |
2000-08-29 |
Smithkline Beecham Plc |
Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
|
EP1157026A1
(en)
|
1999-02-22 |
2001-11-28 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
EE04799B1
(et)
|
1999-03-12 |
2007-04-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
|
ES2251360T3
(es)
|
1999-03-12 |
2006-05-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Compuestos heterociclicos aromaticos en calidad de agentes antiinflamatorios.
|
EE200100492A
(et)
|
1999-03-19 |
2002-12-16 |
Vertex Pharmaceuticals Incorporated |
Ensüümi IMPDH inhibiitorid
|
US6414011B1
(en)
|
1999-03-26 |
2002-07-02 |
Euro-Celtique S.A. |
Aryl substituted pyrazoles, and pyrroles, and the use thereof
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
DE60009480T2
(de)
|
1999-05-05 |
2005-09-01 |
Aventis Pharma Ltd., West Malling |
Harnstoffe als modulatoren der zelladhäsion
|
BR0010524A
(pt)
|
1999-05-14 |
2002-05-28 |
Imclone Systems Inc |
Tratamento de tumores humanos refratários com antagonistas de receptor de fator de crescimento epidérmico
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
ES2253233T3
(es)
|
1999-07-09 |
2006-06-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Procedimiento para sintesis de compuestos de urea heteroaril sustituidos.
|
AU6314900A
(en)
|
1999-07-26 |
2001-02-13 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
ATE321751T1
(de)
|
1999-07-28 |
2006-04-15 |
Kirin Brewery |
Harnstoffderivate als ccr-3 rezeptor-inhibitoren
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
AU1201801A
(en)
|
1999-10-15 |
2001-08-07 |
Van Kampen Group, Inc., The |
Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
|
US6794393B1
(en)
|
1999-10-19 |
2004-09-21 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
MXPA02004879A
(es)
|
1999-11-16 |
2002-08-30 |
Boehringer Ingelheim Pharma |
Derivados de urea como agentes antiinflamatorios.
|
AU2464601A
(en)
|
1999-12-29 |
2001-07-09 |
Wyeth |
Tricyclic protein kinase inhibitors
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
AU2001236698A1
(en)
|
2000-02-07 |
2001-08-14 |
Abbott Gesellschaft Mit Beschrankter Haftung & Company Kommanditgesellschaft |
2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
US6658473B1
(en)
|
2000-02-25 |
2003-12-02 |
Sun Microsystems, Inc. |
Method and apparatus for distributing load in a computer environment
|
ATE284701T1
(de)
|
2000-03-02 |
2005-01-15 |
Ludwig Inst Cancer Res |
Methode zur behandlung von tumoren welche den vaskulären endothelialen wachstumsfaktor d exprimieren
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
DE60112268T2
(de)
|
2000-03-06 |
2006-05-24 |
Astrazeneca Ab |
Verwendung von quinazolinderivate als inhibitoren der angiogenese
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
WO2002007008A1
(en)
|
2000-04-28 |
2002-01-24 |
Ubink Cornelis Hubertus Johann |
Network procurement system
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
EP1311277A4
(en)
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
FIBROSIS MODULATION METHOD
|
WO2002007772A2
(en)
|
2000-07-24 |
2002-01-31 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Improved oral dosage formulations
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
CA2417310A1
(en)
|
2000-08-04 |
2002-02-14 |
Wolff M. Kirsch |
Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
|
JP4993838B2
(ja)
|
2000-08-11 |
2012-08-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
P38のインヒビターとしてのピリジン誘導体
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
DE60027015T2
(de)
|
2000-08-17 |
2006-10-05 |
The Kitasato Institute |
Pseudoerythromycin-derivate
|
CN1518543A
(zh)
|
2000-08-31 |
2004-08-04 |
�Ʒ� |
吡唑衍生物和它们作为蛋白激酶抑制剂的用途
|
US20020055117A1
(en)
|
2000-09-20 |
2002-05-09 |
James Fett |
Methods for detecting prostate cancer
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
ES2318649T3
(es)
|
2000-10-20 |
2009-05-01 |
EISAI R&D MANAGEMENT CO., LTD. |
Procedimiento de preparacion de derivados de 4-fenoxi quinolinas.
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
JP2004513935A
(ja)
|
2000-11-17 |
2004-05-13 |
ノボ ノルディスク アクティーゼルスカブ |
グルカゴンアンタゴニスト/逆アゴニスト
|
CA2429846A1
(en)
|
2000-11-27 |
2002-05-30 |
Eric A. Brill |
System, method, and program for sorting objects
|
KR20030059275A
(ko)
|
2000-11-28 |
2003-07-07 |
화이자 프로덕츠 인크. |
이소티아졸-4-카복사미드의 염 및 과증식-억제제로서의그의 용도
|
WO2002044156A2
(en)
|
2000-11-29 |
2002-06-06 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
WO2002045733A2
(fr)
|
2000-12-08 |
2002-06-13 |
Kyowa Hakko Kogyo Kk |
Preparations orales ayant une action de soulagement des demageaisons ou un effet antiprurigineux
|
AU2002217277B2
(en)
|
2000-12-21 |
2005-06-16 |
Glaxo Group Limited |
Macrolide antibiotics
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
MXPA03006666A
(es)
|
2001-01-25 |
2004-05-31 |
Guilford Pharm Inc |
Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
PT3351246T
(pt)
|
2001-02-19 |
2019-06-07 |
Novartis Pharma Ag |
Derivado de rapamicina para o tratamento de um tumor sólido associado a angiogenese desregulada
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
ES2286267T3
(es)
|
2001-03-07 |
2007-12-01 |
Telik, Inc. |
Diarilureas sustituidas como estimuladoras de mediada por fas.
|
AU2002245709A1
(en)
|
2001-03-23 |
2002-10-08 |
Bayer Corporation |
Rho-kinase inhibitors
|
DE60239931D1
(de)
|
2001-04-02 |
2011-06-16 |
Genentech Inc |
Kombinationstherapie
|
CA2490819A1
(en)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
WO2002083628A1
(en)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzo-fused compounds
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
EP1379505B1
(en)
|
2001-04-20 |
2007-02-28 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
MXPA03009847A
(es)
|
2001-04-27 |
2004-02-12 |
Vertex Pharma |
Inhibidores de cinasa derivados de pirazol.
|
CA2445003A1
(en)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
WO2003004523A1
(en)
|
2001-07-02 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human citron rho/rac-interacting kinase
|
US6916814B2
(en)
|
2001-07-11 |
2005-07-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
SI1450799T1
(sl)
|
2001-12-03 |
2007-02-28 |
Bayer Pharmaceuticals Corp |
Aril secninske spojine v kombinaciji z drugimi citostaticnimi ali citotoksicnimi sredstvi za zdravljenje cloveskih rakov
|
JP2005526008A
(ja)
|
2001-12-04 |
2005-09-02 |
オニックス ファーマシューティカルズ,インコーポレイティド |
癌を処置するためのraf−mek−erk経路インヒビター
|
WO2003056036A2
(en)
|
2001-12-21 |
2003-07-10 |
The Wellcome Trust |
Genes
|
WO2003060111A2
(en)
|
2001-12-24 |
2003-07-24 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
US20050090474A1
(en)
|
2002-01-16 |
2005-04-28 |
Zvi Naor |
Methods and compositions for enhancing and inhibiting fertilization
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
AU2003210969A1
(en)
|
2002-02-11 |
2003-09-04 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenesis inhibiting activity
|
WO2003068746A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Aryl ureas as kinase inhibitors
|
MXPA04007832A
(es)
|
2002-02-11 |
2005-09-08 |
Bayer Pharmaceuticals Corp |
Aril-ureas con actividad inhibitoria de angiogenesis.
|
US20030216396A1
(en)
|
2002-02-11 |
2003-11-20 |
Bayer Corporation |
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
DE60329910D1
(de)
|
2002-03-29 |
2009-12-17 |
Novartis Vaccines & Diagnostic |
Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
|
DE10221524A1
(de)
|
2002-05-14 |
2003-12-04 |
Kmb Produktions Ag Felben |
Verfahren und Vorrichtung zum Herstellen von Verzehrgütern
|
US20040018528A1
(en)
|
2002-05-17 |
2004-01-29 |
Sugen, Inc. |
Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
US20060063782A1
(en)
|
2002-07-03 |
2006-03-23 |
Murray Christopher W |
3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
JP2005539041A
(ja)
|
2002-08-27 |
2005-12-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
Rafキナーゼ阻害剤としてのグリシンアミド誘導体
|
MXPA05002493A
(es)
|
2002-09-05 |
2005-05-27 |
Neurosearch As |
Derivados de diarilurea y su uso como bloqueadores del canal del cloro.
|
PL374758A1
(en)
|
2002-10-24 |
2005-10-31 |
Merck Patent Gmbh |
Methylene urea derivatives
|
JP5354836B2
(ja)
|
2002-11-06 |
2013-11-27 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
プロテアソームインヒビターを使用する癌を処置するための方法および組成物
|
KR20050086648A
(ko)
|
2002-11-15 |
2005-08-30 |
노파르티스 아게 |
약물 전달 시스템
|
NZ540815A
(en)
|
2002-12-06 |
2008-03-28 |
Nycomed Gmbh |
Process for preparing optically pure active compounds
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
JP4594925B2
(ja)
|
2003-02-28 |
2010-12-08 |
ニッポネックス インコーポレイテッド |
増殖亢進性、血管新生性及び炎症性疾患の治療に有用な2−オキソ−1,3,5−パーヒドロトリアザピン誘導体
|
MXPA05009102A
(es)
|
2003-02-28 |
2006-05-31 |
Bayer Pharmaceuticals Corp |
Derivados de piridina sustituida utiles en el tratamiento del cancer y otros trastornos.
|
CA2516931C
(en)
|
2003-02-28 |
2014-09-09 |
Bayer Pharmaceuticals Corporation |
Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
JP2006521304A
(ja)
|
2003-03-24 |
2006-09-21 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
rafキナーゼ阻害剤として有用なオキサミド誘導体
|
WO2004084889A1
(en)
|
2003-03-28 |
2004-10-07 |
Pfizer Inc. |
Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
CA2526617C
(en)
|
2003-05-20 |
2015-04-28 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas with kinase inhibiting activity
|
JP2006526606A
(ja)
|
2003-06-05 |
2006-11-24 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
治療薬としてのシクロアルキル及びヘテロシクロアルキル置換されるベンゾチオフェン
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
WO2005005389A2
(en)
|
2003-07-07 |
2005-01-20 |
Merck Patent Gmbh |
Malonamide derivatives
|
AU2004255340B2
(en)
|
2003-07-08 |
2008-05-01 |
Novartis Ag |
Use of rapamycin and rapamycin derivatives for the treatment of bone loss
|
EP1643991B1
(en)
|
2003-07-11 |
2014-03-12 |
Merck Patent GmbH |
Benzimidazole carboxamides as raf kinase inhibitors
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
EP1653951B1
(en)
|
2003-07-11 |
2011-12-28 |
Merck Patent GmbH |
Benzimidazole derivatives as raf kinase inhibitors
|
WO2005009367A2
(en)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Treatment of diseases with kinase inhibitors
|
UA84156C2
(ru)
|
2003-07-23 |
2008-09-25 |
Байер Фармасьютикалс Корпорейшн |
Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний
|
AR045134A1
(es)
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
US20050069963A1
(en)
|
2003-08-15 |
2005-03-31 |
Lokshin Anna E. |
Multifactorial assay for cancer detection
|
JP2007505938A
(ja)
|
2003-09-23 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
Vegf受容体阻害剤と化学療法剤の組み合わせ
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
US20080045546A1
(en)
|
2003-10-15 |
2008-02-21 |
Axel Bouchon |
Tetradydro-Naphthalene And Urea Derivatives
|
EP1682126B1
(en)
|
2003-10-16 |
2009-07-01 |
Novartis Vaccines and Diagnostics, Inc. |
Substituted benzazoles and use thereof as inhibitors of raf kinase
|
CA2542329A1
(en)
|
2003-10-16 |
2005-04-28 |
Chiron Corporation |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
US7750160B2
(en)
|
2003-11-13 |
2010-07-06 |
Ambit Biosciences Corporation |
Isoxazolyl urea derivatives as kinase modulators
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
KR20060129246A
(ko)
|
2003-12-05 |
2006-12-15 |
컴파운드 쎄라퓨틱스, 인크. |
타입 2 혈관 내피 성장 인자 수용체의 억제제
|
CA2546920A1
(en)
|
2003-12-09 |
2005-06-23 |
Joel Moss |
Methods for suppressing an immune response or treating a proliferative disorder
|
CA2548571A1
(en)
|
2003-12-10 |
2005-06-30 |
Merck Patent Gmbh |
Diacylhydrazine derivatives
|
EP1694865A4
(en)
|
2003-12-12 |
2007-06-06 |
Bayer Pharmaceuticals Corp |
METHOD OF PREDICTING AND PROGNOSING CANCER AND MONITORING ANTICANCER TREATMENT
|
WO2005075425A2
(en)
|
2004-01-30 |
2005-08-18 |
Merck Patent Gmbh |
Substituted bisarylurea derivatives as kinase inhibitors
|
JP2007530453A
(ja)
|
2004-03-19 |
2007-11-01 |
ザ ペン ステート リサーチ ファウンデーション |
黒色腫を治療するためのコンビナトリアル法および組成物
|
EP1751139B1
(en)
|
2004-04-30 |
2011-07-27 |
Bayer HealthCare LLC |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
EP1796642B1
(en)
|
2004-08-27 |
2008-05-21 |
Bayer Pharmaceuticals Corporation |
Pharmaceutical compositions in the form of solid dispersions for the treatment of cancer
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
ES2368930T3
(es)
|
2004-09-06 |
2011-11-23 |
Bayer Pharma Aktiengesellschaft |
Pirazolopirimidinas como inhibidores de proteína cinasa b (akt).
|
SG155996A1
(en)
|
2004-09-29 |
2009-10-29 |
Bayer Schering Pharma Ag |
Thermodynamically stable form of bay 43-9006 tosylate
|
EP1797037B1
(en)
|
2004-09-29 |
2014-12-17 |
Bayer HealthCare LLC |
Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenyoxy}n-methylpyridine-2-carboxamide
|
PL1858877T3
(pl)
|
2005-01-14 |
2014-08-29 |
Gilead Connecticut Inc |
1,3 podstawione diarylem moczniki jako modulatory aktywności kinazy
|
WO2006094262A2
(en)
|
2005-03-03 |
2006-09-08 |
Superimaging, Inc. |
Display
|
SG160364A1
(en)
|
2005-03-07 |
2010-04-29 |
Bayer Schering Pharma Ag |
Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
EP1888067A1
(en)
|
2005-05-27 |
2008-02-20 |
Bayer HealthCare AG |
Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
|
JP2008545670A
(ja)
|
2005-05-27 |
2008-12-18 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
疾患を処置するためのジアリールウレア類を含む組合せ治療
|
WO2007015947A2
(en)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
WO2007021860A2
(en)
|
2005-08-11 |
2007-02-22 |
Bayer Healthcare Llc |
QUANTITATIVE ASSAYS FOR PDGFR-β IN BODY FLUIDS
|
EP1928872B1
(en)
|
2005-09-21 |
2012-03-14 |
4Sc Ag |
Novel sulphonylpyrroles as inhibitors of hdac
|
EA018698B1
(ru)
|
2005-09-21 |
2013-10-30 |
4Сц Аг |
Сульфонилпирролгидрохлориды как ингибиторы гистондезацетилазы
|
AU2006304764A1
(en)
|
2005-10-21 |
2007-04-26 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
US20090215835A1
(en)
|
2005-10-31 |
2009-08-27 |
Scott Wilhelm |
Treatment of cancer with sorafenib
|
US20090068146A1
(en)
|
2005-10-31 |
2009-03-12 |
Scott Wilhelm |
Diaryl ureas and combinations
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
CA2628091A1
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
CN101351709A
(zh)
|
2005-11-02 |
2009-01-21 |
拜尔健康护理有限责任公司 |
癌症的预测和预后以及监控癌症治疗的方法
|
CA2628849A1
(en)
|
2005-11-10 |
2007-05-18 |
Bayer Healthcare Ag |
Diaryl urea for treating pulmonary hypertension
|
DK1948176T3
(da)
|
2005-11-10 |
2011-04-18 |
Bayer Schering Pharma Ag |
Diarylurinstoffer til behandling af pulmonær hypertension
|
EP1963849A2
(en)
|
2005-11-14 |
2008-09-03 |
Bayer Healthcare, LLC |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
CA2629863A1
(en)
|
2005-11-14 |
2007-05-24 |
Scott Wilhelm |
Use of sorafenib for the treatment of cancers with acquired resistance to kit inhibitors
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
JP2009518298A
(ja)
|
2005-12-01 |
2009-05-07 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌治療に有用な尿素化合物
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
US20090197922A1
(en)
|
2006-01-24 |
2009-08-06 |
The University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
AU2007217562A1
(en)
|
2006-02-22 |
2007-08-30 |
4Sc Ag |
Indolopyridines as EG5 kinesin modulators
|
UA96592C2
(uk)
|
2006-02-22 |
2011-11-25 |
4Сц Аг |
Індолопіридини як модулятори кінезину eg5
|
US7908091B2
(en)
|
2006-03-17 |
2011-03-15 |
Prometheus Laboratories Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
WO2007123722A2
(en)
|
2006-03-31 |
2007-11-01 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
EP2338488A1
(en)
|
2006-05-26 |
2011-06-29 |
Bayer HealthCare, LLC |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
MX2009004861A
(es)
|
2006-11-09 |
2009-05-21 |
Abbott Gmbh & Co Kg |
Forma de dosificacion farmaceutica para la administracion oral de inhibidor de tirosina quinasa.
|
ATE498620T1
(de)
|
2006-12-20 |
2011-03-15 |
Bayer Healthcare Llc |
4-ä4-ä(ä3-tert-butyl-1-ä3-(hydroxymethyl)-pheny ü-1h-pyrazol-5-ylü-carbamoyl)-aminoü-3- fluorophenoxyü -n-methylpyridin-2-carboxamid sowie prodrugs und salze davon zur behandlung von krebs
|
JP2010514692A
(ja)
|
2006-12-20 |
2010-05-06 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌の治療に有用なヒドロキシメチルフェニルピラゾリル尿素化合物
|
US8680124B2
(en)
|
2007-01-19 |
2014-03-25 |
Bayer Healthcare Llc |
Treatment of cancers with acquired resistance to kit inhibitors
|
EP2195286A2
(en)
|
2007-09-10 |
2010-06-16 |
Cipla Limited |
Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
|
WO2009054004A2
(en)
|
2007-10-22 |
2009-04-30 |
Natco Pharma Limited |
Process for the preparation of sorafenib
|
JP5753785B2
(ja)
|
2008-11-07 |
2015-07-22 |
ノバベイ・ファーマシューティカルズ・インコーポレイテッドNovabay Pharmaceuticals,Inc. |
抗菌オキサゾリジノン、ヒダントインおよびイミダゾリジノン組成物
|
GB0823587D0
(en)
|
2008-12-29 |
2009-01-28 |
South West Refrigeration |
Dairy heat reclamation system
|
JP5821626B2
(ja)
|
2011-12-27 |
2015-11-24 |
富士ゼロックス株式会社 |
画像形成装置及びプログラム
|